Effect of age on 95% effective dose of remimazolam for loss of consciousness during anesthesia induction in high-risk patients
Not Applicable
- Conditions
- Not Applicable
- Registration Number
- KCT0008547
- Lead Sponsor
- Ajou University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
adult patients with ASA class 3 or higher who can give voluntary consent (20-80 years old)
Exclusion Criteria
Patients with a body mass index (BMI) greater than 30 kg/m2 or less than 20 kg/m2
Patients with contraindications to the study drug, such as allergies or known adverse reactions to the drug
Patients with hearing impairments or other conditions that make it challenging for them to respond to verbal commands from the researchers
Patients who are unable to provide voluntary consent
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effective dose 95
- Secondary Outcome Measures
Name Time Method differences in effective dose values a?ccording to age